7 Reasons Cancer Rates have Skyrocketed since Your Grandparent’s Day that you CAN’T Ignore!!!
Meet Catherine 🙂
Here’s my hypothesis for the top 7 (diet and lifestyle related) reasons why. You’ll be surprised by how many of these you can control:
#1) While Americans are well FED, they are not well nourished.
How can you expect the body to maintain the homeostatis that keeps cancer cells at bay if your body doesn’t have the raw materials to function properly?
From the increases in processed food, the introduction of genetically modified foods (GMOs), to eating fat free diets, and not eating the whole animal (leading to inflammation), it’s clear the majority of Americans are not giving their body the proper nutrition it needs. Read More:
As people live longer: Age is one of the biggest single risk factor for cancer.
Risk increases significantly after age 50, and half of all cancers occur at age 66 and above. According to the National Cancer Institute, one quarter of new cancer diagnoses are in people aged 65 to 74. Read More:
Dr. Bhavesh Balar is a board-certified hematologist and oncologist on staff at CentraState Medical Center in Freehold, NJ, where he also serves as chairman of the hospital’s Cancer Committee.
He is also a medical director at Regional Cancer Care Associates in New Jersey. He contributed this article to Live Science’s Expert Voices: Op-Ed & Insights.
As an oncologist, Dr. Balar is frequently asked why so many people these days are being diagnosed with cancer. Considering the significant in roads made over the past 50 years in terms of cancer research, prevention, diagnosis and treatment, it doesn’t seem to make sense.
The good news is that each of us is more likely to survive a cancer diagnosis and go on to enjoy a high quality of life than at any other time in history. There are estimated to be nearly 14.5 million cancer survivors in the United States.
https://www.livescience.com/51099-the-three-reasons-cancer-rates-are-rising.html
Medical marijuana and the new herbalism, part 1 of 6
The death toll from cancer is changing as new cases increase quicker than prescription drug price.
And After Years of Research, Big Pharma Finally Shows Evidence Cannabis Kills Cancer. Cancer is the second-leading cause of death globally after cardiovascular disease, and the proportion of deaths around the world due to cancer has increased from 12% in 1990 to 15% present day. Even though the National Cancer Institute states otherwise.
And the American Cancer Society saying, “according to annual statistics: The death rate from cancer in the United States having declined steadily over the past 2 decades. In the small town where I live cancer is out of control we have burgeoning cemeteries caused by cancer.
After Years of Research, Big Pharma Finally Shows Evidence Cannabis Kills Cancer
https://www.cancer.gov/about-cancer/understanding/statistics
https://www.cancer.org/latest-news/facts-and-figures-2018-rate-of-deaths-from-cancer-continues-decline.html
https://www.youtube.com/watch?v=LUF33Ojesi4
With that said the #1 Question ask on Facebook: Cannabis Strain vs. Cancer Type… which strain is best for type of cancer?
Marijuana has 34 cures for cancer and is NOT FDA approved Chemotherapy was discovered by poisoning people with mustard gas.
As with all treatments a 100 percent success rate is highly unlikely. But this amazing plant remaining an illegal, schedule 1 drug, and unable to be studied in a larger forum, is a travesty. In this link is a list of 34 studies for the skeptics out there.
Best cannabis oil for cancer https://www.bing.com/videos/search?q=best+cannabis+oil+for+cancer&FORM=HDRSC3
http://www.medicalmarijuanastrains.com/tag/good-for-cancer/
Headlines: Alysa Erwin is now cancer-free, and her family believes cannabis oil saved her life. The following article first appeared in Culture Magazine: At 14 years old, Alysa Erwin was diagnosed with terminal brain cancer. As it would with any family, the news hit hard.
https://cannabis.net/blog/medical/cannabis-for-glioma-brain-cancer
All over the world Cannabis oil has come under scrutiny…. in the United Kingdom
By Alison George
Cannabis is in the headlines for its potential medical benefits after the recent confiscation of cannabis oil medication from the mother of a 12-year-old British boy with severe epilepsy.
The furore that ensued is shining a light on campaigns for cannabis oils to be made legal for medical reasons, and the UK government has now announced a review into the use of medicinal cannabis. Here’s what you need to know. https://www.newscientist.com/article/2172415-cannabis-oil-what-is-it-and-does-it-really-work-as-medicine/
One of the most sought after answers on Facebook is cancer strains for my type of cancer and dosage information? Therefore, in this blog I will try to key in on Lung, Liver, Breast, Prostate, Pancreatic, Esophageal and Cervical cancer and also the strains of cannabis one should consider. Even though one strain might work for one but not the other. Cannabis Quality may differ also from one dispensary to another and they all feel.. they do it better than the other 🙁
This is a cool Quora Q&A link about cannabis I thought interesting
https://www.quora.com/What-Cannabis-strains-would-you-recommend-for-cancer-patients-who-are-diagnosed-as-terminally-ill-and-why
https://potent.media/how-to-use-cannabis-as-medicine
https://www.theglobeandmail.com/life/health-and-fitness/health/five-maps-that-put-cancers-global-spread-into-focus/article16679285/
https://www.cureyourowncancer.org/dosage.html
Cannabis Strains: Do Cannabis Strains Differ?
Cannabis consumers have always maintained that different types (strains, or chemical varieties, chemovars) produce distinct effects, whether this be with respect to their psychoactivity or to their therapeutic attributes.
Strains are often designated as sativa, indica, or a hybrid. These labels are quite misleading as applied in the marketplace, however. In contrast, the scientific community has generally focused on tetrahydrocannabinol (THC) as the primary or only important variable.
It is clear that until very recently, selective breeding in cannabis for the recreational and medicinal markets have produced THC-predominant cannabis to the exclusion of other cannabinoids. Some researchers have stressed the importance of additional components, especially terpenoids, the aromatic components of cannabis that like cannabinoids are produced in glandular trichomes, as important modulators of cannabis effects (McPartland & Russo, 2001, Russo 2011).
What are other cannabinoids in cannabis?
The most common phytocannabinoid besides THC is cannabidiol (CBD). It was previously common in cannabis landraces from Afghanistan and Morocco, for example, however, has largely disappeared from recreational cannabis. It is also present in hemp fibre and seed strains, but usually in low titre.
In the medicinal arena, CBD has received increasing attention due to its many medicinal attributes, including its pain-relieving and anti-inflammatory benefits without intoxication or sedation.
It also reduces side effects of THC when administered concomitantly, specifically, anxiety and tachycardia. Taken together, the two components may demonstrate synergy in many applications.
Another cannabis component of interest is tetrahydrocannabivarin (THCV), traditionally found in small amounts in Southern African cannabis chemovars (chemical varieties).
It is currently under investigation as a treatment for metabolic syndrome, often seen as a prelude to the development of Type II diabetes.
Other phytocannabinoids under investigation include cannabigerol (CBG) for prostate cancer, cannabidivarin (CBDV) for epilepsy, and several others.
What about terpenoids?
Abundant evidence supports that these low concentration components contribute to the phytocannabinoids in whole cannabis preparations by adding their own therapeutic benefits or allaying side effects of THC.
Worthy of particular mention are limonene, with known anti-depressant effects, pinene, which attenuates short-term memory deficits engendered by THC, myrcene, which is sedating, and beta-caryophyllene, which stimulates the non-psychoactive CB2 receptor, and produces anti-inflammatory and analgesic effects. Further research will address the relative importance of these agents in various cannabis preparations.
About the author:
Dr. Ethan Russo is a board-certified neurologist, who also serves as Senior Medical Advisor to GW Pharmaceuticals. He is a past chairman of the International Association for Cannabinoid Medicines, and is the current president of the International Cannabinoid Research Society.
Additional Reading:
Fischedick, J. T., Hazekamp, A., Erkelens, T., Choi, Y. H. & Verpoorte, R. (2010). Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry, 71, 2058-73.
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V. & Mechoulam, R. (2009). Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci, 30, 515-27.
Russo, E. B. (2007). History of cannabis and its preparations in saga, science and sobriquet. Chemistry & Biodiversity, 4, 2624-2648.
Angel Teger (Ruby Doobie Edibles and Los Angeles Medical Cannabis Task Force) and Dave Rubin discuss medical and recreational marijuana, types of cannabis, growing your own medication, and more.
Josh Bachynski, director of marketing and outreach at Harvest Medicine Cannabis Clinic gives a primer on marijuana, the difference between CBD and THC, the different strains, how it can be consumed, and how marijuana prescriptions can be used to treat the various conditions, watch video below!!! 🙂